Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

32.20 -0.10 (-0.31%)

Streaming Delayed Price Updated: 11:31 AM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

29 30 Next >

MarketBeat Week in Review – 03/17 - 03/21

March 22, 2025

Stocks gained after the Fed meeting but drifted lower after disappointing guidance from FedEx; next week's inflation data is unlikely to provide needed clarity

Via MarketBeat

10 Health Care Stocks Whale Activity In Today's Session ↗

March 21, 2025

Via Benzinga

1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street ↗

March 20, 2025

Via The Motley Fool

Is Viking Therapeutics a Buy Right Now? ↗

February 26, 2025

Via The Motley Fool

$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today ↗

February 11, 2025

Via Benzinga

2 Stocks to Buy With Less Than $40 ↗

February 10, 2025

Via The Motley Fool

Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy? ↗

March 19, 2025

Via The Motley Fool

Is Novo Nordisk a No-Brainer Buy After It Dropped 40%? ↗

March 19, 2025

Via The Motley Fool

Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?

March 18, 2025

Viking Therapeutic may have a GLP-1 blockbuster on their hands with VK2735 as it produces weight loss at 5X the speed of Novo Nordisk's Wegovy GLP-1 drug.

Via MarketBeat

Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped ↗

March 12, 2025

Ignore the noise in GLP-1 stocks. Find the best value instead.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

March 11, 2025

Via Benzinga

2 Stocks That Could Soar Again in 2025 ↗

February 08, 2025

Via The Motley Fool

Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled. ↗

March 11, 2025

The company will pay CordenPharma $150 million over three years in a manufacturing deal.

Via Investor's Business Daily

Is Eli Lilly Stock a Buy? ↗

March 11, 2025

Via The Motley Fool

The State of Weight Loss Drugs ↗

March 10, 2025

Via The Motley Fool

BJ's Wholesale Club Posts Better-Than-Expected Earnings, Joins Burlington Stores, Veeva Systems And Other Big Stocks Moving Higher On Thursday ↗

March 06, 2025

Via Benzinga

AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion. ↗

March 03, 2025

This is the drugmaker's first foray into weight-loss drugs. And it's not focusing on GLP-1.

Via Investor's Business Daily

MarketBeat Week in Review – 02/24 - 02/28

March 01, 2025

Stocks tried to stage a weak rally to close the week but the short-term outlook will continue to be dictated by the uncertainty that is creating volatility

Via MarketBeat

Topics Economy World Trade

1 Biotech Stock to Buy in 2025, and 1 to Avoid ↗

February 28, 2025

Via The Motley Fool

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%. ↗

February 28, 2025

Via The Motley Fool

Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?

February 26, 2025

Viking Therapeutics stock jumped on rumors of a potential acquirer looking to add a GLP-1 treatment to their portfolio and VK2735 appears to rival Zepbound.

Via MarketBeat

Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk ↗

February 24, 2025

Via The Motley Fool

Garmin Posts Better-Than-Expected Results, Joins SolarEdge Technologies, Compass, Appian And Other Big Stocks Moving Higher On Wednesday ↗

February 19, 2025

Via Benzinga

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

February 13, 2025

Via Benzinga

Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today ↗

February 10, 2025

Via The Motley Fool

3 No-Brainer Healthcare Stocks to Buy With $200 Right Now ↗

February 10, 2025

Via The Motley Fool

Down 65%, Is Viking Therapeutics Stock a Buy on the Dip? ↗

February 08, 2025

Via The Motley Fool

Viking Therapeutics Stock Down Over 20% In 2025: Retail Traders Predict Where It Could End The Year ↗

February 07, 2025

In 2024, Viking reported positive results from four different clinical trials, including a Phase 2 study for subcutaneous VK2735 and a Phase 1 trial of an oral tablet form of VK2735 to treat obesity.

Via Stocktwits

We Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug Wars ↗

February 07, 2025

Lilly’s fiercest competitor in the obesity market is Novo Nordisk, which offers Ozempic and Wegovy. However, rising threats from other players such as Hims & Hers, Amgen, and Viking Therapeutics also...

Via Stocktwits

Market Movers: $ASTS Surges Again, $PBI Gears Up For Earnings! ↗

February 06, 2025

Pre-Market Briefing: Feb 6 – Top trade setups using our 4-pillar strategy! $ASTS leads the way, $PBI gears up for earnings, and $PTON & $APPS ride post-earnings momentum.

Via Talk Markets

Topics Stocks / Equities

< Previous 1 2 3 4 5 6 7 8 9

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.